New eye injection safety tested for Age-Related vision loss
NCT ID NCT07214740
Summary
This study tested the safety of pegcetacoplan eye injections delivered via a prefilled syringe for people with geographic atrophy, a form of age-related macular degeneration that causes progressive vision loss. It involved 44 participants aged 60 and older who were already candidates for this treatment. The main goal was to monitor for any eye-related side effects from the injections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Austin Retina Associates
Austin, Texas, 78705, United States
-
California Retina Consultants
Bakersfield, California, 93309, United States
-
California Retina Consultants
Oxnard, California, 93036, United States
-
Retina Consultants of Texas
Katy, Texas, 77494, United States
-
Retina Consultants of Texas
Woodland, Texas, 77384, United States
Conditions
Explore the condition pages connected to this study.